Inovio Trims Team as Trouble Brews at FDA for Rare Disease Candidate on March 13, 2026 Accelerated Approved Inovio Pharmaceuticals layoffs Rare Diseases Recurrent respiratory papillomatosis United States Food and Drug Administration +